Letter to the EditorI petitioned the FDA to restrict hypnotics: here is why
Section snippets
Conflict of interest
The ICMJE Uniform Disclosure Form for Potential Conflicts of Interest associated with this article can be viewed by clicking on the following link: http://dx.doi.org/10.1016/j.sleep.2015.12.011.
References (12)
- et al.
Hypnotics' association with mortality or cancer: a matched cohort study
BMJ Open
(2012) - et al.
Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study
BMJ
(2014) - et al.
Zolpidem and driving impairment – identifying persons at risk
N Engl J Med
(2013) Mortality risk of hypnotics: strengths and limits of evidence
Drug Saf
(2015)- et al.
Adverse respiratory events associated with hypnotics use in patients of chronic obstructive pulmonary disease: a population-based case-control study
Medicine (Baltimore)
(2015) - et al.
Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century
PNAS
(2015)
There are more references available in the full text version of this article.
Cited by (0)
© 2015 Elsevier B.V. All rights reserved.